Previous in vitro studies for ARVC have found that inhibition of DSG2 binding, or mutation of DSG2 protein, disrupts intercalated discs and subsequently the cell to cell contact necessary for cardiomyocyte adhesion. Here, DSG2 is linked to Arrhythmogenic right ventricular dysplasia.